ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)
$22.54 0.27 (1.2124%)
Analysed ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) News Sources
Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial
30-06-2026
yahoo.com
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
09-07-2026
yahoo.com
An Adaptive Biotechnologies Insider Sold $8.5 Million in Stock After an 85% Run
12-07-2026
fool.com
Are Medical Stocks Lagging DexCom (DXCM) This Year?
21-07-2026
yahoo.com
Adaptive Biotechnologies (ADPT) Upgraded to Buy: What Does It Mean for the Stock?
21-07-2026
yahoo.com
Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
22-07-2026
yahoo.com
Will Earnings Estimate Upgrades and a Smaller Projected Loss Change Adaptive Biotechnologies' (ADPT) Narrative?
23-07-2026
yahoo.com
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
23-07-2026
yahoo.com
Adaptive Biotechnologies (ADPT) Stock May Be 22% Undervalued As Growth Hopes Build
24-07-2026
yahoo.com
Adaptive Biotechnologies (ADPT) After Loss Forecasts Improve Is The Rally Already Priced In
24-07-2026
yahoo.com
What is the current price of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)?
The current price of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) is $22.54.
ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) since the previous trading day is $0.27.
ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) since the previous trading day is 1.2124%.
What is the most recent average sentiment score for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)?
The most recent average sentiment score for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)?
The most recent sentiment for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) is .
SEC-8K** Filing Available For ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.